학술논문

Breakthrough pain in patients with multiple myeloma: a secondary analysis of IOPS MS study
Document Type
article
Source
European Review for Medical and Pharmacological Sciences, Vol 27 (2023)
Subject
Therapeutics. Pharmacology
RM1-950
Language
English
ISSN
1128-3602
Abstract
OBJECTIVE: The aim of this study was to characterize breakthrough pain (BTcP) in patients with multiple myeloma (MM). PATIENTS AND METHODS: This was a secondary analysis of a large multicenter study of patients with BTcP. Background pain intensity and opioid doses were recorded. The BTcP characteristics, including the number of BTcP episodes, intensity, onset, duration, predictability, and interference with daily activities were recorded. Opioids prescribed for BTcP, time to achieve a meaningful pain relief after taking a medication, adverse effects, and patients’ satisfaction were assessed. RESULTS: Fifty-four patients with MM were examined. In comparison with other tumors, in patients with MM BTcP was more predictable (p=0.04), with the predominant trigger being the physical activity (p